PALISADE BIO INC (PALI:NASDAQ)
$2.02 -0.01 (-0.4926%)
Analysed PALISADE BIO INC (PALI:NASDAQ) News Sources
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
18-05-2026
yahoo.com
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
21-05-2026
fool.com
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
21-05-2026
fool.com
Palisade Bio to Participate in the Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
09-06-2026
yahoo.com
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11-06-2026
yahoo.com
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
29-06-2026
yahoo.com
PALI Stock Heads For Best Day In Seven Months – What’s Driving Today’s Rally?
29-06-2026
stocktwits.com
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
10-07-2026
yahoo.com
Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
27-07-2026
yahoo.com
What is the current price of PALISADE BIO INC (PALI:NASDAQ)?
The current price of PALISADE BIO INC (PALI:NASDAQ) is $2.02.
PALISADE BIO INC (PALI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is $-0.01.
PALISADE BIO INC (PALI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is -0.4926%.
What is the most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ)?
The most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for PALISADE BIO INC (PALI:NASDAQ)?
The most recent sentiment for PALISADE BIO INC (PALI:NASDAQ) is .
SEC-8K** Filing Available For PALISADE BIO INC (PALI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.